Medpace Holdings EPS - Earnings per Share 2014-2025 | MEDP
Medpace Holdings annual and quarterly earnings per share history from 2014 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Medpace Holdings EPS for the quarter ending March 31, 2025 was $3.67, a 14.69% increase year-over-year.
- Medpace Holdings EPS for the twelve months ending March 31, 2025 was $13.10, a 33.54% increase year-over-year.
- Medpace Holdings 2024 annual EPS was $12.63, a 42.23% increase from 2023.
- Medpace Holdings 2023 annual EPS was $8.88, a 21.98% increase from 2022.
- Medpace Holdings 2022 annual EPS was $7.28, a 51.35% increase from 2021.
| Medpace Holdings Annual EPS | |
|---|---|
| 2024 | $12.63 |
| 2023 | $8.88 |
| 2022 | $7.28 |
| 2021 | $4.81 |
| 2020 | $3.84 |
| 2019 | $2.67 |
| 2018 | $1.97 |
| 2017 | $0.98 |
| 2016 | $0.37 |
| 2015 | $-0.28 |
| 2014 | $-0.50 |
| 2013 | $0.95 |
| Medpace Holdings Quarterly EPS | |
|---|---|
| 2025-03-31 | $3.67 |
| 2024-12-31 | $3.67 |
| 2024-09-30 | $3.01 |
| 2024-06-30 | $2.75 |
| 2024-03-31 | $3.20 |
| 2023-12-31 | $2.46 |
| 2023-09-30 | $2.22 |
| 2023-06-30 | $1.93 |
| 2023-03-31 | $2.27 |
| 2022-12-31 | $2.08 |
| 2022-09-30 | $2.05 |
| 2022-06-30 | $1.46 |
| 2022-03-31 | $1.69 |
| 2021-12-31 | $1.32 |
| 2021-09-30 | $1.29 |
| 2021-06-30 | $1.06 |
| 2021-03-31 | $1.14 |
| 2020-12-31 | $1.35 |
| 2020-09-30 | $1.09 |
| 2020-06-30 | $0.64 |
| 2020-03-31 | $0.76 |
| 2019-12-31 | $0.80 |
| 2019-09-30 | $0.63 |
| 2019-06-30 | $0.73 |
| 2019-03-31 | $0.51 |
| 2018-12-31 | $0.60 |
| 2018-09-30 | $0.52 |
| 2018-06-30 | $0.45 |
| 2018-03-31 | $0.40 |
| 2017-12-31 | $0.30 |
| 2017-09-30 | $0.25 |
| 2017-06-30 | $0.23 |
| 2017-03-31 | $0.20 |
| 2016-12-31 | $-0.02 |
| 2016-09-30 | $0.13 |
| 2016-06-30 | $0.15 |
| 2016-03-31 | $0.11 |
| 2015-12-31 | $0.00 |
| 2015-09-30 | $0.00 |
| 2014-12-31 | $0.00 |
| 2013-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $9.166B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.869B | 26.80 |
| CVS Health (CVS) | United States | $84.351B | 10.48 |
| Elevance Health (ELV) | United States | $78.372B | 10.11 |
| Cencora (COR) | United States | $58.632B | 20.40 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $21.669B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.584B | 17.51 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.511B | 0.00 |
| Solventum (SOLV) | United States | $13.191B | 13.96 |
| CochLear (CHEOY) | Australia | $12.755B | 0.00 |
| ICON (ICLR) | Ireland | $11.919B | 11.08 |
| Revvity (RVTY) | United States | $11.635B | 20.02 |
| Viatris (VTRS) | United States | $10.798B | 3.71 |
| Avantor (AVTR) | United States | $9.206B | 13.38 |
| HealthEquity (HQY) | United States | $8.806B | 38.57 |
| Sonic Healthcare (SKHHY) | Australia | $8.474B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.559B | 14.81 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.749B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.885B | 28.77 |
| BrightSpring Health Services (BTSG) | United States | $3.868B | 35.48 |
| Sotera Health (SHC) | United States | $3.236B | 18.39 |
| Surgery Partners (SGRY) | United States | $2.823B | 36.72 |
| Concentras Parent (CON) | United States | $2.608B | 15.07 |
| Alignment Healthcare (ALHC) | United States | $2.600B | 0.00 |
| Organon (OGN) | United States | $2.527B | 2.69 |
| GeneDx Holdings (WGS) | United States | $2.446B | 94.22 |
| Ardent Health (ARDT) | United States | $1.902B | 8.11 |
| PACS (PACS) | United States | $1.902B | 0.00 |
| Progyny (PGNY) | United States | $1.839B | 40.47 |
| Premier (PINC) | United States | $1.812B | 13.75 |
| GoodRx Holdings (GDRX) | United States | $1.693B | 33.86 |
| Teladoc Health (TDOC) | United States | $1.416B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.333B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.155B | 8.79 |
| CareDx (CDNA) | United States | $1.027B | 16.04 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.965B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.813B | 7.61 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Nutex Health (NUTX) | United States | $0.698B | 10.57 |
| Embecta (EMBC) | United States | $0.586B | 3.95 |
| InnovAge Holding (INNV) | United States | $0.563B | 0.00 |
| LifeMD (LFMD) | United States | $0.554B | 0.00 |
| Omada Health (OMDA) | $0.481B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.467B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| So-Young (SY) | China | $0.436B | 0.00 |
| Enhabit (EHAB) | United States | $0.371B | 30.50 |
| Performant Healthcare (PHLT) | United States | $0.329B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.310B | 0.00 |
| Beauty Health (SKIN) | United States | $0.277B | 0.00 |
| Oncology Institute (TOI) | United States | $0.228B | 0.00 |
| DocGo (DCGO) | United States | $0.155B | 25.33 |
| Pheton Holdings (PTHL) | China | $0.129B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.091B | 0.00 |
| KindlyMD (NAKA) | United States | $0.073B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| OpGen (OPGN) | United States | $0.051B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |